NCT03246464

Brief Summary

Myopia is a common disease of the eye with increasing prevalence in the Western World as well as in South East Asia where 60-90% of the children are affected. High myopia is associated with an increasing risk of sight threatening complications such as retinal detachment, glaucoma, macular choroidal degeneration and myopic choroidal neovascularization. In myopia the eye is elongated compared to an emmetropic eye. If the elongation of the eye can be controlled the progression of myopia can be controlled. Asian studies have shown reduction in axial length growth by 36-46% in children using orthokeratology contact lenses (OKL). OKL are custom fit, form stable lenses. During sleep the cornea is reshaped creating an emmetropic vision during the day, so no glasses or contact lenses are needed. Twin and family studies have shown a high heritability for the development of myopia, and more than 40 genetic loci have been identified indicating that the effect of OKL in Asian children might not be the same in North European children which is why we want to execute a similar study on North European children. Purpose:

  1. 1.Investigate if nightly wear of OKL reduces the progression of childhood myopia (change in axial length) in Danish children when compared to a control group using monofocal glasses.
  2. 2.Investigate the safety (Efron score) of OKL.
  3. 3.Investigate children's quality of life impact of refractive correction (questionnaire) using OKL compared to glasses.
  4. 4.Identify possible predictors for progression of myopia (AC/A ratio, peripheral defocus and higher order aberrations).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 11, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 11, 2017

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 17, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 17, 2020

Completed
Last Updated

May 28, 2020

Status Verified

May 1, 2020

Enrollment Period

3.1 years

First QC Date

July 11, 2017

Last Update Submit

May 27, 2020

Conditions

Keywords

Contact lensesChildrenMyopia

Outcome Measures

Primary Outcomes (1)

  • Progression of myopia defined as change in axial length 18 months after start of intervention

    Follow up to 18 months

Secondary Outcomes (3)

  • Quality of life comparison between myopic children wearing glasses and orthokeratology lenses using the Pediatric Refractive Error Profile 2 Questionnaire

    Follow up to 18 months

  • Safety evaluation by Efron scores for orthokeratology lenses

    Follow up to 18 months

  • Accommodation and higher-order aberrations

    Follow up to 18 months

Study Arms (2)

Single-vision spectacles

PLACEBO COMPARATOR
Device: Single-vision spectacles

Orthokeratology lenses

ACTIVE COMPARATOR
Device: Orthokeratology lenses

Interventions

Rigid gas permeable contact lenses

Orthokeratology lenses

Regular single vision spectacles

Single-vision spectacles

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Myopia -0.5 to -4.75 dioptries spherical in one or both eyes.
  • Regular astigmatism ≤ -2.5 diopters in one or both eyes.
  • Age 6 ≥ 12 years.
  • Anisometropia \< 1.5 D spherical equivalent.
  • Best corrected visual acuity of 0.1 logMAR or better in both eyes.
  • Acceptance of treatment randomization.

You may not qualify if:

  • Manifest or latent squint.
  • Contraindications to the use of OKL comprising keratoconus, allergic conjunctivitis and keratoconjunctivitis sicca.
  • Previous eye surgery.
  • Chronic eye disease demanding daily use of eye drops.
  • Non-compliance to eye examinations (unstable fixation or intolerance to OKL).
  • One or both parents being ethnical Asian, African, Hispanic or Spanish.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vejle Hospital

Vejle, Jylland, 7100, Denmark

Location

Related Publications (1)

  • Cerullo C, Moller F, Ewan R, Norgaard B, Jakobsen TM. Vision-related quality of life in children: Cross-cultural adaptation and test-retest reliability of the Danish version of the paediatric refractive error profile 2. Acta Ophthalmol. 2024 Sep;102(6):e970-e983. doi: 10.1111/aos.16685. Epub 2024 Apr 13.

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized controled clinical interventional trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2017

First Posted

August 11, 2017

Study Start

March 1, 2017

Primary Completion

April 17, 2020

Study Completion

April 17, 2020

Last Updated

May 28, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

IPD is not to be shared with other researchers.

Locations